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The full set of microRNAs (miRNAs) in the human
genome is not known. Because presently known
miRNAs have been identified by virtue of their abun-
dant expression in a few cell types, many tissue-
specific miRNAs remain unrevealed. To understand
the role of miRNAs in B cell function and lymphoma-
genesis, we generated short-RNA libraries from
normal human B cells at different stages of develop-
ment (naive, germinal center, memory) and from
aBurkitt lymphomacell line. A combination of cloning
and computational analysis identified 178 miRNAs
(miRNome) expressed in normal and/or transformed
B cell libraries. Most notably, the B cell miRNome
included 75 miRNAs which to our knowledge have
not been previously reported and of which 66 have
been validated byRNAblot and/or RT-PCR analyses.
Numerous miRNAs were expressed in a stage- or
transformation-specific fashion in B cells, suggesting
specific functional or pathologic roles. These results
provide a resource for studying the role of miRNAs
in B cell development, immune function, and lympho-
magenesis.
INTRODUCTION
A novel mechanism of post-transcriptional regulation has been
revealed with the discovery of microRNAs (miRNAs), a class of
short RNAs that impair translation or induce mRNA degradation
by binding to the 30 untranslated region of target mRNA (Bartel,
2004; Kim, 2005). A recent release of the miRBase database
(v.11.0) (Griffiths-Jones, 2006; Griffiths-Jones et al., 2006)
reports 847 human miRNAs. However, the discovery of miRNAs
is still an on-going process with variable predictions about the
total number of miRNAs expressed in mammalian cells ranging744 Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc.from one thousand to several thousands (Bentwich et al.,
2005; Miranda et al., 2006). The reported miRNAs have been
identified from a limited number of cell types or from tissues
whose cellular heterogeneity may favor the identification of ubiq-
uitous and abundant miRNA. In fact, a recent report aiming for
the identification ofmiRNA expression profiles from a large panel
of different mammalian tissues and cell types led to the
discovery of only 12 previously unreported humanmiRNA (Land-
graf et al., 2007). These findings led to the conclusion that most
miRNAs are known and that most of them are ubiquitously
expressed (Landgraf et al., 2007). Nonetheless, additional anal-
yses of purified cell populations have led to the identification of
tissue- and stage of differentiation-specific miRNAs in a few
tissues, suggesting the existence of tissue-specific miRNA
expression (Calabrese et al., 2007; Cummins et al., 2006).
The role of miRNAs in B lymphocyte development and B cell
lymphomagenesis is largely unknown. A critical stage of the
differentiation process leading to effector B cells is represented
by the germinal centers (GC), the structures that develop when
mature naive B cells encounter the antigen in the secondary
lymphoid organs and are stimulated to proliferate and differen-
tiate into GC centroblasts (CB). During the GC reaction, B cells
undergo somatic hypermutation of their immunoglobulin-vari-
able regions and class switch recombination. B cells that have
acquired the ability to express high-affinity immunoglobulins
are then positively selected and further differentiate into the final
effectors of the humoral immune response, i.e., memory B cells
and plasma cells (Klein and Dalla-Favera, 2008). Naive, GC, and
memory B cells are also relevant targets of disease because
each of these B cell subpopulations can be affected by malig-
nant transformation leading to different types of lymphomas
and leukemias (Klein and Dalla-Favera, 2008; Kuppers and
Dalla-Favera, 2001).
Several initial observations suggest an important role of
specific miRNAs in B cell function and malignancy. Via mouse
models, miR-155 has been demonstrated to affect regulation
of the GC response through modulation of cytokine production
(Rodriguez et al., 2007; Thai et al., 2007) and by direct
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deaminase (AID) (Dorsett et al., 2008; Teng et al., 2008).
Recently, miR-150 has been shown to target MYB, a critical tran-
scription factor involved in the control of B cell differentiation
(Xiao et al., 2007). In B cell lymphomas, 13q31 amplification
has been associated with the overexpression of the miR-17-92
cluster and its enforced expression in a murine B cell lymphoma
model showed a role in accelerating tumor development (He
et al., 2005). Furthermore, miR-15a and miR-16 have been impli-
cated in the pathogenesis of B cell chronic lymphocytic leukemia
(CLL) (Calin et al., 2002, 2005).
As a basis for a comprehensive analysis of the role of miRNAs
in B cell function and lymphomagenesis, this study was aimed at
identifying the miRNAs expressed (miRNome) in the human
mature B cell compartment, including naive, GC, and memory
B cells. By using a combination of cloning and computational
analysis, we report the identification of 178miRNAs representing
the mature B cell miRNome, including 75 previously unreported
miRNAs. The results show that normal B cell subpopulations are
characterized by specific miRNA ‘‘signatures,’’ suggesting func-
tional roles ofmiRNAs in B cell differentiation and transformation.
RESULTS
Construction of Short-RNA Libraries from Human
B Cell Subpopulations
Short-RNA libraries were generated by cloning RNA fractions of
15–30 nt from human centroblasts, naive, and memory B cells
purified from tonsils, as well as from the Burkitt lymphoma cell
line Ramos, which is representative of malignant transformation
of GC B cells. Approximately 3,500 sequences were analyzed
from each library, corresponding to 13,788 total short-RNAs
(2,632 nonredundant sequences). By using a bootstrap
approach (Harrell, 2001; Davison and Hinkley, 1997), we esti-
mated that more than 85% of the complexity of the libraries
has been examined (Figure S1 and Supplemental Experimental
Procedures available online).
Mapping of Short-RNA Sequences
to the Human Genome
The cloned sequences were subjected to a computational anal-
ysis (see Supplemental Experimental Procedures) summarized
in the flowchart illustrated in Figure S2. Each cloned sequence
was first matched to the human genome assembly (March
2006, hg18) to retrieve the genomic regions from which the short
RNAs originated. One or more genomic locations were identified
for 2086 (80%) of the cloned sequences considering both
perfect matches and single mismatches (Figure S2). Consistent
with previous observations, 30-end mismatches were the most
common and showed a clear preference for A in the last position
(data not shown) (Neilson et al., 2007). The failure of 546 short-
RNA sequences to align with the human genome is likely due,
at least in part, to errors introduced by PCR during the cloning
procedure (Figure S2). However, a small subset of these short
RNAs lacking a corresponding genomic region in Homo sapiens
have been cloned with high frequencies in multiple libraries and
showed differential expression during B cell differentiation (data
not shown), suggesting that they may represent bona fide short-
RNA species, which cannot be mapped on the current referencegenome probably because of polymorphisms and/or post-tran-
scriptional modifications. However, given the difficulty of assign-
ing genomic coordinates to these sequences, they were omitted
from further analyses (see Discussion).
Computational Prediction of Precursor
and Mature miRNAs
In order to identify candidate miRNAs among the cloned short-
RNA sequences, we developed a computational pipeline aiming
at the identification of potential miRNA precursors based on the
investigation of their genomic location and folding characteristics
(Figure S3 and Supplemental Experimental Procedures). In brief,
short RNA sequences were mapped to the human genome and
their respective candidate genomic precursors (±90 nt) were
retrieved and analyzed for secondary structure, size and energy
of the loop, and number of complimentary base pairs in the
stem of the loop (Supplemental Experimental Procedures). The
prediction was performed on the full set of nonredundant short
RNAs (2632 sequences) for which one ormore genomic locations
couldbe identified (FigureS2). Theanalysis led to the identification
of candidate miRNA precursors for 1646 short-RNA sequences,
which were then clustered allowing for (1) the variability observed
at thematuremiRNA 30 ends (and less dramatically at the 50 ends)
includingnucleotidesubstitutions anddeletions, and (2) thepossi-
bility of miRNA editing as previously reported (Kawahara et al.,
2007; Luciano et al., 2004) (Supplemental Experimental Proce-
dures). After annotating each candidate mature miRNA, those
which matched mRNA, rRNA, tRNA, post-transcriptionally modi-
fied t-RNA, and other ncRNA (yRNA, sn/snoRNA) sequences, and
werepresent onlyonce in the librarieswerenot considered further.
The remaining sequenceswere still consideredmiRNAsbased on
criteria (identification of genomic loci consistent with a pre-
miRNA, length, recurrence, differential expression, detection in
the Ago complex) that suggest their existence as bona fide
miRNA. Moreover, consistent with the miRNA length of the
Homo sapiensmiRBase database (v11.0), only mature candidate
miRNAs of length 17–28 nt were considered.
Overall, the analysis identified 178 mature miRNAs, of which
103 were known and 75 were not previously reported, to our
knowledge (Table S1 and Figure S2). Computational prediction
of precursor miRNAs (pre-miRNA) identified 114 precursors
already reported to potentially code for the 103 known mature
miRNA, and 274 genomic locations containing novel candidate
pre-miRNA associated with the 75 previously unreported and 8
known mature miRNAs (Figure 1 and Table S1).
A sizeable number of sequences (334) aligned to genomic
regions that did not fulfill the criteria for miRNA precursors
(Figure S2). About 80% of these sequences were annotated or
cloned only once and may represent degradation products
originating from other RNA species (Figure S2 and Table S2).
The remaining (58 sequences), however, mapped to genomic
regions that lack annotations and may therefore represent
a part of the transcriptome whose functions are unknown (Table
S3 and Table S4). Interestingly, several of these nonannotated
sequences (i.e., CU-5004, CU-5021, CU-6030, CU-6069) were
cloned multiple times and showed differential expression across
libraries (Table S3 and Table S4), suggesting that they may
represent short RNAs with characteristics distinct from those
currently recognized in ‘‘classic’’ miRNAs.Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc. 745
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normal and neoplastic B cells led to the identification of 178
mature miRNAs cloned multiple times as well as other short-
RNA species of unknown function.
Abundance and Evolutionary Conservation
Previously reported miRNAs appeared to be generally more
abundant than newly discovered miRNAs. Approximately 50%
of previously reported miRNAs appeared in the libraries with
more than 10 occurrences compared to 29% of the newly
discovered miRNAs (Figure 2A). Moreover, 48% of known
miRNAs were expressed at all stages of mature B cell develop-
ment, whereas newly identified miRNAs showed a more distinct
stage specificity (Figure 2B), consistent with the notion that pres-
ently known miRNAs are mostly representative of ubiquitously
expressed miRNAs (see Discussion).
In order to investigate the presence of orthologous miRNA in
other mammalian species, we relied on UCSC-provided Blastz
pairwise alignments between human and target species and
investigated conservation with two complementary methods,
detailed in Supplemental Experimental Procedures. The analysis
was performed on the complete set of miRNAs deposited in the
miRBase database and on the miRNAs (known and new) repre-
sented in the B cell libraries. Alignments of the human mature
miRNA to its target species were required to have either perfect
conservation of the entire mature miRNA sequence or conserva-
tion of seeds composed of seven bases starting from the second
position of the human mature sequence followed by conserva-
tion of three bases starting from the 12th, 13th, or 14th position
as suggested by Grimson et al. (2007) (Figure 2C; Table S5).
The majority of miRBase-miRNAs showed conservation
across mammalian genomes, from primates to rodents. Conser-
vation frequency mimicked known phylogenetic distances to
human, with the highest conservation in chimp and lowest in
rat. The conservation frequencies of known and newly identified
miRNAs in B cells were similar in chimp (Pan troglodytes) and
monkey (Macacus rhesus), especially when conservation
requirements were restricted to the seed region of miRNAs.
Figure 1. Predicted Precursor and Mature miRNAs
The number of predicted precursor miRNAs (pre-miR) and mature miRNAs
(mature-miR) are plotted independently for each library and overall.
Throughout the figures, the sequences matching miRNAs deposited in the
miRBase database (v.11.0) are defined as ‘‘known,’’ and the sequences that
to our knowledge have not been previously reported are named ‘‘new.’’746 Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc.However, conservation frequencies in dog, mouse, and rat
were significantly divergent, with known miRNAs more likely to
exhibit conservation than new candidate miRNAs (Figure 2C;
Table S5). In summary, previously unreported miRNAs ex-
pressed at specific stages of B cell differentiation were generally
less abundant and showed a lower degree of conservation
across species, as shown for other tissue-specific miRNAs
(see Discussion).
Validation of Previously Unreported miRNAs
All 75 newly identified miRNAs were investigated by RT-PCR
analysis in order to independently validate their existence
in vivo in B cell lines and cells isolated from tonsils. Positive
results were obtained in 66 of the cases (see Figure 3A for repre-
sentative results and Table S6). Eighteen previously unreported
miRNAs were also tested by RNA blot analysis and 11 were
detectable (Figure 3B; Table S6), either via total cellular RNA or
upon enrichment for the short-RNA fraction. Overall, 88% of
the newly cloned and computationally validated miRNAs were
detectable by RNA blot and/or RT-PCR. The validation process
also led to the identification of numerous miRNA that are differ-
entially regulated either in normal versus transformed cells (see
examples CU-1440, CU-1241, CU-1276, and CU-1137 in
Figure 3) as well as during the GC reaction (see below Figure 4
and data not shown).
In order to gain preliminary evidence of the functionality of the
previously unreported miRNAs, a small subset of these miRNAs
that were fully validated at the expression level was tested for
incorporation in the functional miRNA-mRNA complex by coim-
munoprecipitation with Ago2 proteins (Mourelatos et al., 2002).
The results showed that the RNA fraction associated with the
Ago complex was indeed enriched for each of the four tested
previously unreported miRNAs (Figure S4), confirming that the
identified sequences enter the expected miRNA functional
pathway.
Indirect clues on the functionality of miRNAs may also be
obtained, analyzing the effect of stage-specific miRNAs on the
corresponding transcriptome because most miRNAs have
been shown to affect the expression of their targets albeit to
a modest degree (Filipowicz et al., 2008). Toward this end, the
targets of 15 previously unreported GC-overexpressed miRNAs
were predicted by two algorithms (miRanda and RNA22) (John
et al., 2004; Miranda et al., 2006) and were tested for enrichment
in genes downregulated in GC versus naive B cells. Eleven out of
fifteen miRNA showed an increase (and only two a decrease) in
their candidate target enrichment p value for GC downregulated
genes compared to control populations (Figure S5 and Table
S7). These results suggest that indeed miRNAs associated
with GC B cells specifically affect the GC transcriptome.
In summary, previously unreported miRNAs identified by
cloning and computational analysis were validated at the expres-
sion level by multiple detection methods. For the small subset
tested, their incorporation in the Ago complex and their activity
on the GC transcriptome suggests biological functionality.
Transcriptional and Post-Transcriptional Regulation
Most newly identified miRNAs tested by RNA blot showed a long
abundant transcript (>150 nt) likely corresponding to the primary
miRNA transcript and a second transcript (60–80 nt) consistent
Immunity
Identification of the Human Mature B Cell miRNomeFigure 2. Abundance and Evolutionary Conservation of the B Cell miRNome
(A) Frequencies of previously reported (known) and to our knowledge newly identified (new) miRNAs as occurring in naive, centroblasts, memory, and Ramos
cells. Single occurrences miRNAs are not included.
(B) Number of miRNAs cloned multiple times and identified in naive, centroblasts, and memory B cells. A larger overlap is observed for known compared to new
miRNA (48% versus 38%).
(C) Conservation analysis for orthologous miRNAs was performed in five mammal species for all miRNA reported in the miRBase database (miRBase-all) and for
known and newmature miRNA expressed in the B cell libraries. The percentages of miRNAs having either perfect conservation for the entire mature miRNA (top)
or for its seed (bottom) are displayed.with the precursor miRNA. As shown in Figure 3C (top), the
precursor miRNA and the correspondent mature miRNA may be
produced in some cell type but not in others, suggesting transcrip-
tional regulation. Conversely, the relative abundance of precursor
and mature miRNA was different is some cell types (Figure 3C,
bottom), suggesting the existence of post-transcriptional regula-
tionmost likely targeting theDicer-dependentpre-miRNAprocess-
ing (Lee et al., 2007; Michael et al., 2003; Thomson et al., 2006).
Taken together, these observations suggest that the expres-
sion of mature miRNAs may be affected by both transcriptional
and post-transcriptional regulatory mechanisms.
Distinct miRNA Signatures in Normal B Cell
Subpopulations
In order to further investigate whether specific miRNA regulation
occurred in normal B cell development or in transformed cells,we examined miRNA representation in the libraries constructed
from naive, GC, and memory B cells, as well as from the Ramos
BL cell line. Differential expression of numerous known and
newly identified miRNAs was evident during B cell differentiation
and GC transit as shown by hierarchical clustering via miRNA
frequencies (defined as the fraction of the total pool of cloned
miRNAs represented by a given miRNA in a library) obtained
from the cloning data (Figure 4A). Naive and memory B cells
appeared similar, sharing a large fraction of the most abundant
miRNAs. Conversely, centroblasts showed a more distinct
miRNA profile, with a sizeable fraction of abundant miRNAs
being specifically expressed in the CB library, suggesting
specific functions. Some miRNAs were expressed in the GC-
derived Ramos cells, but not in normal GC B cells, or vice versa
in the normal but not in the tumor cells, suggesting thatmalignant
transformation affects miRNA expression.Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc. 747
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Identification of the Human Mature B Cell miRNomeFigure 3. Detection of Previously Unreported miRNAs by RT-PCR and RNA Blot
(A) Representative results of RT-PCR detection of miRNA in Ramos cell line and tonsil cells. miR-30c was used as loading control.
(B) Detection of mature miRNA species by RNA blot in Ramos cell line, centroblasts (CB), and naive B cells isolated from human tonsils. RNU44 was used as
loading control.
(C) RNA blot images displaying both the mature (20–25 nt) and the precursor (60–80 nt) miRNA species. miRNA expression can be regulated at transcriptional
level (top) or at the processing level (bottom) when intermediate forms (pre-miRNA) are generated but are not fully processed to mature miRNA. The naming of
miRNAs is provisional.To independently validate the results of the cloning experi-
ment, we also performed miRNA expression profiling of centro-
blasts, naı¨ve, and memory B cells (six donors/each) by using
a commercial microarray representative of 723 known human
miRNAs (miRBase v.10.1). The Spearman correlation between
cloning and microarray data is 0.7 corresponding to a p value
< 3.9e-28 (Figure S6). Each B cell population showed a distinct
miRNA expression profile. Consistent with the cloning data
(Figure 4A), GC B cells appeared to be quite distinct from naive
and memory B cells, which instead shared expression of a large
fraction of miRNAs (Figure 4B). The expression of several
miRNAs was tested by qRT-PCR analysis, which confirmed
that the microarray data were quantitatively accurate (data not
shown). Overall, these results show that the GC reaction is char-
acterized by the specific expression of multiple miRNAs.
DISCUSSION
The combination of cloning procedures and computational tools
used in this study led to the identification of a large fraction of
miRNA expressed during B cell differentiation. These included748 Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc.75 previously unreported miRNAs, as well as a potentially
distinct class of short RNAs not fulfilling current criteria for
miRNAs. These findings have general implications for the under-
standing of the total miRNA content of the human genome as
well as for future studies on the role of miRNAs in B cell differen-
tiation, function, and lymphomagenesis.
The discovery of 75 previously unreported miRNAs expressed
in normal and/or malignant B cells is in contrast with a previous
study that reported the discovery of only 12 new human miRNA
(Landgraf et al., 2007) from an analysis of a large panel of
different organ systems and cell types and suggested that
most miRNAs have already been identified and are ubiquitously
expressed (Landgraf et al., 2007). These discordant results and
conclusions may be due (1) to the higher number of clones per
library sequenced in this study (3500 versus 1300 on average
in Landgraf et al. [2007]), which allowed the detection of low-
abundance miRNA species, and (2) to the criteria applied in the
miRNA identification that do not include conservation and allow
consideration of repetitive elements (see Supplemental Experi-
mental Procedures). Moreover, the relatively lower degree of
evolutionary conservation of previously unreported miRNAs
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via murine libraries (Chen et al., 2004; Neilson et al., 2007).
Consistent with these observations, a recent report on short
RNAs in mouse embryonic stem cells discovered Dicer-depen-
dent miRNAs characterized by both low abundance and low
degree of conservation (Calabrese et al., 2007). Because 88%
Figure 4. miRNA Expression Profiling
Distinguishes Developmental Stages of
Normal as well as Malignant B Cells
(A) Unsupervised clustering performed via miRNA
frequencies values (R0.08) calculated as the
fraction of the total pool of cloned miRNAs repre-
sented by a given miRNA in a library.
(B) Unsupervised clustering of microarray-based
miRNA expression profiles distinguishes centro-
blasts, naive, and memory B cells purified from
tonsil tissue of six patients/each.
of the previously unreported miRNAs
have been independently detected by
RT-PCR and/or RNA blot analyses, our
cloning and computational approach is
largely validated.
We note that a fraction of the validated
miRNAs display similarity to the 30 end of
post-transcriptionally modified tRNAs,
raising the possibility that theymay derive
from loci with t-RNA homology or by
direct processing of t-RNAs. We also
identified a large set of candidate
miRNAs (101 unreported, to our knowl-
edge, and 27 known) that have been
cloned as single occurrences in the
B cell libraries (Table S1). This group of
candidate miRNAs has not yet been fully
investigated, but nevertheless they may
include bona fide miRNAs because 3
out of 3 tested were detectable by RNA
blot or RT-PCR analyses (data not
shown). Thus, our data in B cells suggest
that a large number of low-abundance,
recently evolved, tissue-specific miRNAs
remain to be discovered.
Two categories of short RNAs were
identified that could not be annotated as
bona fide miRNAs. The first category is
represented by short RNAs that display
all features required by the computational
pipeline to be defined as candidate
miRNAs, but nevertheless have an atyp-
ical length (<17 nt or >28 nt; 75 candidate
miRNAs). Sequences belonging to this
first category may include bona fide
miRNAs because 2 out of 2 tested were
detectable by RT-PCR. The second cate-
gory is represented by those short RNAs
for which classic pre-miRNA structures
could not be identified in the genome
and no similarity to other noncoding RNA was found in the avail-
able databases. These short RNAs either may be miRNA for
which RNA secondary structure prediction algorithms failed to
predict the correct hairpin structure or may represent novel
miRNA species of presently unknown mechanism of generation
or other not yet described types of short RNAs.Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc. 749
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could not be accurately mapped to the genome. Considering
that a fraction of these RNAs were cloned multiple times and
showed a stage-specific behavior, we suggest that such short
RNAs do actually exist and that the lack of a match to the human
genome may be due to polymorphisms, editing, and other post-
transcriptional modifications or to an incomplete or inaccurate
sequencing of the corresponding genomic regions.
The specificity in mature miRNA expression appears to be
regulated at the transcriptional as well as at the post-transcrip-
tional, i.e., pre-miRNA processing, level. Indeed, the accumula-
tion of pre-miRNA in absence of a mature miRNA can occur
in a cell type-restricted manner, suggesting the presence of
a mechanism of regulation at the pre-miRNA processing step.
Both regulatory mechanisms may act during normal differentia-
tion and may also be dysregulated during transformation as
a consequence of genetic or epigenetic alterations (Lee et al.,
2007; Michael et al., 2003; Thomson et al., 2006). Indeed,
miRNAs CU-1137 and CU-1368 represent examples of tran-
scriptional activation and post-transcriptional silencing associ-
ated with malignant transformation, respectively.
The stage-specific expression of various miRNAs strongly
suggests highly specialized regulatory functions in B cell biology.
The role of miRNAs that show cell type-specific functions in
lymphocytes has just begun to be elucidated (Dorsett et al.,
2008; Li et al., 2007; Rodriguez et al., 2007; Teng et al., 2008;
Thai et al., 2007; Xiao et al., 2007). ThemiRNAs specifically asso-
ciated with GC or non-GC B cells by either cloning or miRNA
expression profiling have not been previously reported in B cell
differentiation with the exception of miR-150 (Xiao et al., 2007).
For example, the miR-199 and miR-125 families as well as
miR-138 show a distinct expression in GC B cells although
none of these miRNAs has been investigated for a role in this
cell compartment. The extent of post-transcriptional regulation
added by miRNAs will be fully uncovered only in the context of
the complex network of cellular interactions (Basso et al.,
2005), which will require the integration of large-scale gene
and miRNA expression data.
miRNA expression can be affected by malignant transforma-
tion. For instance, the miR-17-92 cluster, previously reported
as a potential oncogene (He et al., 2005), was found overex-
pressed in Ramos cell line compared to GC B cells. Moreover,
several miRNAs (i.e., CU-1137, CU-1148) show expression in
Ramos cells and in several additional BL cell lines (data not
shown), but not in their normal GC counterpart. Vice versa, as
observed for the miR-199 family, the expression of some
miRNAs is lost in the tumor cells. The data herein represents
a useful basis to investigate whether lymphoma-associated
chromosomal lesions affect genomic regions associated with
miRNA expression.
Finally, the differences in miRNA expression profile between
GC and non-GC B cells resembled those observed by expres-
sion profiling of coding genes (Klein et al., 2003), consistent
with the previous observation that miRNA profiling may be
equally or more informative in discriminating tumor phenotypes
(Calin et al., 2005; Lu et al., 2005). This suggests that miRNA
expression profiling, especially if including novel B cell-specific
miRNAs, may be useful in the differential diagnosis of lymphoid
malignancies.750 Immunity 30, 744–752, May 22, 2009 ª2009 Elsevier Inc.The expanded B cell miRNome described here represents
a resource that can be used to identify miRNAs expressed during
the GC transit as well as specific differences in miRNA expres-
sion in normal versus lymphoma cells, and which can guide
studies to unveil the function ofmiRNAs in normal B cell develop-
ment and lymphomagenesis.
EXPERIMENTAL PROCEDURES
Generation of Short-RNA Libraries
Purification of naive, memory, and GC B cells was performed as previously
reported (Klein et al., 2003) by using magnetic cell sorting of mononucleated
cells obtained from human tonsils. Tissue collection was performed at the
Babies and Children’s Hospital of Columbia-Presbyterian Medical Center
and was approved by the institutional ethical committee. Total RNA was puri-
fied with the Trizol Reagent (Invitrogen) according to the manufacturer’s indi-
cations. The short-RNA libraries were generated by an established protocol
described in detail in Lau et al. (2001). In brief, total RNA was separated on
15%polyacrylamide gel and the fragment corresponding to 15–30 nucleotides
length was excised. The purified small RNAs were linked to adaptor oligonu-
cleotides and gel purified. Upon adaptor ligation, RNAwas reverse transcribed
and cDNA was PCR amplified and cloned into pCR2.1-TOPO vector (Invitro-
gen). Sequencing was performed on colony PCR amplicons.
Computational Identification of Precursor and Mature miRNAs
The bioinformatics miRNA analysis pipeline (Figure S3) includes (1) identifica-
tion of short RNAs from each library, (2) identification of exact and partial
matches of the short-RNA sequences to the human genome, (3) testing
each short-RNA genomic region for compatibility with hairpin secondary struc-
tures, (4) clustering genomic regions to predict mature miRNAs, (5) annotating
and filtering short RNAs and miRNAs candidates, (6) estimation of predicted
miRNA frequencies in the libraries, and (7) clustering short RNAs that do not
support miRNA candidates. The details are reported in the Supplemental
Experimental Procedures.
Orthology Analysis
The identification of putative orthologous sequences of known and predicted
precursor and mature human miRNAs in chimp (panTro2), monkey (rheMac2),
dog (canFam2), mouse (mm8), and rat (rn4) was performed with UCSC-
provided Blastz (Schwartz et al., 2003) pairwise alignments between human
and target species. The details are reported in the Supplemental Experimental
Procedures.
miRNA Expression Profiling
ThemiRNA expression profiles were generated with the HumanmiRNAMicro-
array kit (Agilent Technologies) that allows detection of 723 known human
(miRBase v.10.1) and 76 human viral miRNAs, according to themanufacturer’s
indications. Analysis of raw data was performed with the Feature Extraction
Software 9.5.3.1 (Agilent Technologies). The dendrograms (Figure 4) were
generated with a hierarchical clustering algorithm based on the average-
linkagemethod (Eisen et al., 1998; Hartigan, 1975) and Spearman’s correlation
as provided by the geWorkbench platform (http://www.geworkbench.org).
RT-PCR Analysis
Small RNA fractions were purified with the Trizol Reagent (Invitrogen) and the
PureLink miRNA Isolation Kit (Invitrogen), according to the manufacturer’s
indications. RT-PCR was performed as previously described (Sharbati-
Tehrani et al., 2008). In brief, miRNA sequences were reverse-transcribed
from 50 ng short RNA via Superscript III First Strand Synthesis Kit (Invitrogen),
in the presence of 0.2 mMRTFS primer (miRNA-specific primers, see Table S8).
1/10th of the cDNA volume was then used as template for 34 cycles of PCR
amplification in the presence of 4 nM SS primer (miRNA-specific primers,
see Table S8) and 0.4 mM each of MPF and MPR universal primers (Table
S8). PCR products were separated on 12% nondenaturing polyacrylamide
gel, detected by SybrGold (1:10,000 dilution; Invitrogen) and visualized under
UV light.
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Total RNA and small RNA fractions were purified with the Trizol Reagent
(Invitrogen) and the PureLink miRNA Isolation Kit (Invitrogen), respectively,
according to the manufacturer’s indications. Electrophoresis was performed
on 15% denaturing polyacrylamide gel and then RNA was transferred on
Duralon UV membrane (Stratagene) with a semidry transfer apparatus. Prehy-
bridization and hybridization were performed in 53 SSC, 20 mM Na2HPO4
(pH 7.2), 7% SDS, 33 Denhardt’s Solution. Oligonucleotide probes were
[g-32P]ATP labeled by polynucleotide kinase (Fermentas). The list of oligonu-
cleotides and their hybridization temperature is reported in Table S8. After
overnight hybridization, membranes were washed at the same temperature
in 33 SSC, 25 mM NaH2PO4 (pH 7.5), 5% SDS, 103 Denhardt’s Solution for
15–20 min and in 13 SSC, 1% SDS for 5 min. Images were obtained by expo-
sure to phosphoimager cassette and acquisition by Storm 840 Phosphoim-
ager (Molecular Dynamics) and by film exposure for approximately 2 weeks.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, six
figures, and eight tables and can be found with this article online at http://
www.cell.com/immunity/supplemental/S1074-7613(09)00188-5.
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